Skip to main content
SpringerLink
Log in

Pharmacotherapy of Alcohol Dependence: Treatment Readiness and Compliance Barriers

  • Reference work entry
  • First Online:
NeuroPsychopharmacotherapy

  • 33 Accesses

Abstract

Pharmacological treatments for alcohol use disorders have proven efficacy. However, only a minority of treated individuals receive pharmacotherapy. Moreover, in the majority of cases, treatment duration is too short and does not follow recommendations of guidelines. A number of barriers have been identified that are related to the poor adoption of pharmacotherapy for alcohol use disorders including characteristics of the system (e.g., lack of advocacy or treatment services, poor reimbursement for treatment), provider-based barriers (e.g., lack of knowledge or confidence, reluctance to prescribe pharmacotherapy), and patient characteristics (e.g., no interest in pharmacotherapy, poor access to care, fear of side-effects or stigmatization). Studies have tried to improve availability and adherence of pharmacological treatment of AUD. Patients’ attitudes towards pharmacological treatment have not been sufficiently investigated which might help to improve adoption.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 949.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,399.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Abraham AJ, Andrews CM, Harris SJ, Friedmann PD. Availability of medications for the treatment of alcohol and opioid use disorder in the USA. Neurotherapeutics. 2020;17(1):55–69.

    CAS  PubMed  PubMed Central  Google Scholar 

  • American Psychiatric Association, editor. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.

    Google Scholar 

  • Anderson P, Kaner E, Wutzke S, Wensing M, Grol R, Heather N, Saunders J. Attitudes and management of alcohol problems in general practice: descriptive analysis based on findings of a world health organization international collaborative survey. Alcohol Alcohol. 2003;38(6):597–601.

    PubMed  Google Scholar 

  • Anderson P, Wojnar M, Jakubczyk A, Gual A, Reynolds J, Segura L, Sovinova H, Csemy L, Kaner E, Newbury-Birch D, Fornasin A, Struzzo P, Ronda G, van Steenkiste B, Keurhorst M, Laurant M, Ribeiro C, do Rosario F, Alves I, Scafato E, Gandin C, Kolsek M. Managing alcohol problems in general practice in Europe: results from the European ODHIN survey of general practitioners. Alcohol Alcohol. 2014;49(5):531–9.

    PubMed  Google Scholar 

  • Bride BE, Abraham AJ, Kintzle S, Roman PM. Social workers’ knowledge and perceptions of effectiveness and acceptability of medication assisted treatment of substance use disorders. Soc Work Health Care. 2013;52(1):43–58.

    PubMed  PubMed Central  Google Scholar 

  • Cheng HY, McGuinness LA, Elbers RG, MacArthur GJ, Taylor A, McAleenan A, Dawson S, Lopez-Lopez JA, Higgins JPT, Cowlishaw S, Lingford-Hughes A, Hickman M, Kessler D. Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis. BMJ. 2020;371:m3934.

    PubMed  PubMed Central  Google Scholar 

  • Dawson DA. Correlates of past-year status among treated and untreated persons with former alcohol dependence: United States, 1992. Alcohol Clin Exp Res. 1996;20:771–9.

    CAS  PubMed  Google Scholar 

  • Degenhardt L, Charlson F, Ferrari A, Santomauro D, Erskine H, Mantilla-Herrara A, Whiteford H, Leung J, Naghavi M, Griswold M, Rehm J, Hall W, Sartorius B, Scott J, Vollset SE, Knudsen AK, Haro JM, Patton G, Kopec J, Malta DC, Topor-Madry R, McGrath J, Haagsma J, Allebeck P, Phillips M, Salomon J, Hay S, Foreman K, Lim S, Mokdad A, Smith M, Gakidou E, Murray C, Vos T, GBD 2016 Alcohol and Drug Use Collaborators. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5(12):987–1012.

    Google Scholar 

  • Ducharme LJ, Knudsen HK, Roman PM. Trends in the adoption of medications for alcohol dependence. J Clin Psychopharmacol. 2006;26(Suppl 1):S13–9.

    PubMed  Google Scholar 

  • England PH. Adult substance misuse treatment statistics 2019 to 2020: report. London: PHE; 2020. Available from: www.gov.uk/government/publications/substance-misuse-treatment-for-adults-statistics-2019-to-2020/adult-substance-misuse-treatment-statistics-2019-to-2020-report

  • Fairbanks J, Umbreit A, Kolla BP, Karpyak VM, Schneekloth TD, Loukianova LL, Sinha S. Evidence-based pharmacotherapies for alcohol use disorder: clinical pearls. Mayo Clin Proc. 2020;95(9):1964–77.

    CAS  PubMed  Google Scholar 

  • Finlay AK, Ellerbe LS, Wong JJ, Timko C, Rubinsky AD, Gupta S, Bowe TR, Burden JL, Harris AHS. Barriers to and facilitators of pharmacotherapy for alcohol use disorder in VA residential treatment programs. J Subst Abus Treat. 2017;77:38–43.

    Google Scholar 

  • Goh ET, Morgan MY. Review article: pharmacotherapy for alcohol dependence – the why, the what and the wherefore. Aliment Pharmacol Ther. 2017;45(7):865–82.

    CAS  PubMed  Google Scholar 

  • Haber PS, Morley KC. The impact of alcohol pharmacotherapies on public health in Australia is limited by low prescribing rates. Public Health Res Pract. 2016;26(4):4.

    Google Scholar 

  • Harris AHS, Ellerbe L, Reeder RN, Bowe T, Gordon AJ, Hagedorn H, Oliva E, Lembke A, Kivlahan D, Trafton JA. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. Psychol Serv. 2013;10(4):410–9.

    PubMed  Google Scholar 

  • Heather N. Effectiveness of brief interventions proved beyond reasonable doubt. Addiction. 2002;97:293–9.

    PubMed  Google Scholar 

  • Hendershot CS, Wardell JD, Samokhvalov AV, Rehm J. Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies. Addict Biol. 2017;22(6):1515–27.

    CAS  PubMed  Google Scholar 

  • Jonas DE, Amick HR, Feltner C, Bobashev G, Thomas K, Wines R, Kim MM, Shanahan E, Gass CE, Rowe CJ, Garbutt JC. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014;311(18):1889–900.

    PubMed  Google Scholar 

  • Kranzler HR, Soyka M. Diagnosis and pharmacotherapy of alcohol use disorder a review. JAMA J Am Med Assoc. 2018;320(8):815–24.

    CAS  Google Scholar 

  • Kranzler HR, Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res. 2001;25(9):1335–41.

    CAS  PubMed  Google Scholar 

  • Lundahl B, Moleni T, Burke BL, Butters R, Tollefson D, Butler C, Rollnick S. Motivational interviewing in medical care settings: a systematic review and meta-analysis of randomized controlled trials. Patient Educ Couns. 2013;93(2):157–68.

    PubMed  Google Scholar 

  • Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW. Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction. 2013;108(2):275–93.

    PubMed  Google Scholar 

  • Mark TL, Kranzler HR, Poole VH, Hagen CA, McLeod C, Crosse S. Barriers to the use of medications to treat alcoholism. Am J Addict. 2003;12(4):281–94.

    PubMed  Google Scholar 

  • Mekonen T, Chan GCK, Connor J, Hall W, Hides L, Leung J. Treatment rates for alcohol use disorders: a systematic review and meta-analysis. Addiction. 2020; Nov 27. Epub ahead of print.

    Google Scholar 

  • Miller WR, Wilbourne PL. Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction. 2002;97(3):265–77.

    PubMed  Google Scholar 

  • Morley KC, Logge W, Pearson SA, Baillie A, Haber PS. National trends in alcohol pharmacotherapy: findings from an Australian claims database. Drug Alcohol Depend. 2016;166:254–7.

    CAS  PubMed  Google Scholar 

  • NICE. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence (Clinical guideline 115, CG115). National Institute for Health and Care Excellence; 2011.

    Google Scholar 

  • Oliva EM, Maisel NC, Gordon AJ, Harris AH. Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Curr Psychiatry Rep. 2011;13(5):374–81.

    PubMed  PubMed Central  Google Scholar 

  • Oser CB, Roman PM. Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers. J Stud Alcohol Drugs. 2007;68(6):852–61.

    PubMed  Google Scholar 

  • Oslin DW, Lynch KG, Maisto SA, Lantinga LJ, McKay JR, Possemato K, Ingram E, Wierzbicki M. A randomized clinical trial of alcohol care management delivered in Department of Veterans Affairs primary care clinics versus specialty addiction treatment. J Gen Intern Med. 2014;29(1):162–8.

    PubMed  Google Scholar 

  • Palacio A, Garay D, Langer B, Taylor J, Wood BA, Tamariz L. Motivational interviewing improves medication adherence: a systematic review and meta-analysis. J Gen Intern Med. 2016;31(8):929–40.

    PubMed  PubMed Central  Google Scholar 

  • Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, Giovino GA, West R, Hall W, Griffiths P, Ali R, Gowing L, Marsden J, Ferrari AJ, Grebely J, Farrell M, Degenhardt L. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction. 2018;113(10):1905–26.

    PubMed  Google Scholar 

  • Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders a systematic review and meta-analysis. JAMA Netw Open. 2020;3(6):15.

    Google Scholar 

  • Rehm J, Shield KD. Global Burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 2019;21(2):7.

    Google Scholar 

  • Rittenberg A, Hines AL, Alvanzo AAH, Chander G. Correlates of alcohol use disorder pharmacotherapy receipt in medically insured patients. Drug Alcohol Depend. 2020;214:108174.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Robinson S, Bowe T, Harris AH. Group management of pharmacotherapy for alcohol dependence: feasibility and impact on adoption. J Subst Abus Treat. 2013;45(5):475–7.

    Google Scholar 

  • Roman PM, Abraham AJ, Knudsen HK. Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation. Addict Behav. 2011;36(6):584–9.

    PubMed  PubMed Central  Google Scholar 

  • Rotenberg JR, Leong SH, Maisto SA, McKay JR, Possemato K, Ingram E, Oslin DW. Post-intervention durability of alcohol care management: 1-year follow-up of a randomized controlled trial. J Gen Intern Med. 2018;33(10):1626–8.

    PubMed  PubMed Central  Google Scholar 

  • Rubinsky AD, Chen C, Batki SL, Williams EC, Harris AH. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses. J Psychiatr Res. 2015;69:150–7.

    PubMed  Google Scholar 

  • Rumpf HJ, Bischof G, Hapke U, Meyer C, John U. Studies on natural recovery from alcohol dependence: sample selection bias by media solicitation? Addiction. 2000;95(5):765–75.

    CAS  PubMed  Google Scholar 

  • Rumpf HJ, Bischof G, Hapke U, Meyer C, John U. Stability of remission from alcohol dependence without formal help. Alcohol Alcohol. 2006;41(3):311–4.

    PubMed  Google Scholar 

  • Saxon AJ, McCarty D. Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs. Pharmacol Ther. 2005;108(1):119–28.

    CAS  PubMed  Google Scholar 

  • Soyka M, Rösner S. Pharmacotherapy of alcohol withdrawal: update and new developments. Nervenarzt. 2021;92(1):57–65.

    Google Scholar 

  • Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology. 2004;47(Suppl 1):3–13.

    CAS  PubMed  Google Scholar 

  • Walker JR, Korte JE, McRae-Clark AL, Hartwell KJ. Adherence across FDA-approved medications for alcohol use disorder in a veterans administration population. J Stud Alcohol Drugs. 2019;80(5):572–7.

    PubMed  PubMed Central  Google Scholar 

  • Watkins KE, Hunter SB, Cohen CC, Leamon I, Hurley B, McCreary M, Ober AJ. Organizational capacity and readiness to provide medication for individuals with co-occurring alcohol use disorders in public mental health settings. Admin Pol Ment Health. 2021;11

    Google Scholar 

  • Weiss RD. Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction. 2004;99(11):1382–92.

    PubMed  Google Scholar 

  • Willenbring ML. The past and future of research on treatment of alcohol dependence. Alcohol Res Health. 2010;33(1–2):55–63.

    PubMed  PubMed Central  Google Scholar 

  • Williams EC, Achtmeyer CE, Young JP, Berger D, Curran G, Bradley KA, Richards J, Siegel MB, Ludman EJ, Lapham GT, Forehand M, Harris AHS. Barriers to and facilitators of alcohol use disorder pharmacotherapy in primary care: a qualitative study in five VA clinics. J Gen Intern Med. 2018;33(3):258–67.

    PubMed  Google Scholar 

  • Williams EC, Matson TE, Harris AHS. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions. Addict Sci Clin Pract. 2019;14(1):6.

    PubMed  PubMed Central  Google Scholar 

  • World Health Organization. Global status report on alcohol and health 2018. Geneva: World Health Organization; 2018a. Contract No.: Licence: CC BY-NC-SA 3.0 IGO

    Google Scholar 

  • World Health Organization. ICD-11 for Mortality and Morbidity Statistics. Mental, behavioural or neurodevelopmental disorders. World Health Organisation; 2018b [cited 2019 January 30]. Available from: https://icd.who.int/browse11/l-m/en

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychotherapy, Translational Psychiatry Unit, University of Lübeck, Lübeck, Germany

    Hans-Jürgen Rumpf, Gallus Bischof, Samantha Schlossarek & Stefan Borgwardt

Authors
  1. Hans-Jürgen Rumpf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gallus Bischof
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samantha Schlossarek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stefan Borgwardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans-Jürgen Rumpf .

Editor information

Editors and Affiliations

  1. Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Wuerzburg, Wuerzburg, Germany

    Peter Riederer

  2. Institute of Psychological Medicine (IPM), Soyen, Germany

    Gerd Laux

  3. Centre for Research Promotion and Support, Fujita Health University, Toyoake, Aichi, Japan

    Toshiharu Nagatsu

  4. Center Translational Res Neurol Diseases, Dalian Med Uni Shanghai Inst Health Sc Center Translational Res Neurol Diseases, Dalian, China

    Weidong Le

  5. Würzburg, Germany

    Christian Riederer

Section Editor information

  1. Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, Univsersity of Hospital Würzburg, Würzburg, Germany

    Peter Riederer

  2. Department of Psychiatry, University of South Denmark, Odense, Denmark

    Peter Riederer

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Rumpf, HJ., Bischof, G., Schlossarek, S., Borgwardt, S. (2022). Pharmacotherapy of Alcohol Dependence: Treatment Readiness and Compliance Barriers. In: Riederer, P., Laux, G., Nagatsu, T., Le, W., Riederer, C. (eds) NeuroPsychopharmacotherapy. Springer, Cham. https://doi.org/10.1007/978-3-030-62059-2_438

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-62059-2_438

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-62058-5

  • Online ISBN: 978-3-030-62059-2

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation